How I treat acute and chronic leukemia in pregnancy

Blood Reviews

Volumn 22, Issue 5, 2008, Pages 247-259

  Shapira, Tal ^a   Pereg, David ^a,b   Lishner, Michael ^a,b  

^a MEIR MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Breast feeding; Chemotherapy; Fetus; Leukemia; Malformations; Pregnancy

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTHRACYCLINE DERIVATIVE; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; ANTINEOPLASTIC AGENT; CEPHALOSPORIN DERIVATIVE; CYTARABINE; CYTOTOXIC AGENT; DAUNORUBICIN; DOXORUBICIN; ERYTHROMYCIN; ETOPOSIDE; FLUCONAZOLE; FLUCYTOSINE; GRANULOCYTE COLONY STIMULATING FACTOR; IDARUBICIN; INTERFERON; KETOCONAZOLE; MERCAPTOPURINE; METOCLOPRAMIDE; METRONIDAZOLE; PENICILLIN DERIVATIVE; PREDNISONE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RETINOIC ACID; SULFONAMIDE; TETRACYCLINE DERIVATIVE; TIOGUANINE; UNINDEXED DRUG; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BACTERIAL INFECTION; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CARDIOMYOPATHY; CARDIOTOXICITY; CHRONIC LEUKEMIA; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONGENITAL HEART MALFORMATION; DELIVERY; EMBRYOTOXICITY; FEBRILE NEUTROPENIA; FETUS MALFORMATION; FETUS MORTALITY; FETUS OUTCOME; FIRST TRIMESTER PREGNANCY; HEART INJURY; HEART MUSCLE INJURY; HUMAN; INFECTION; LEUKAPHERESIS; MYCOSIS; NEURAL TUBE DEFECT; NEUTROPENIA; NONHUMAN; PREGNANCY; PREGNANCY TERMINATION; PRIORITY JOURNAL; RISK ASSESSMENT; SIDE EFFECT; STEM CELL TRANSPLANTATION; TERATOGENESIS; TERATOGENICITY; TREATMENT OUTCOME;

ABORTION, INDUCED; ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; LEUKEMIA; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; PREGNANCY TRIMESTERS; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 48149085904     PISSN: 0268960X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.blre.2008.03.006     Document Type: Article

References (111)

1. Pentheroudakis G., and Pavlidis N. Cancer and pregnancy: poema magna, not anymore. Eur J Cancer 42 (2006) 126-140
2. Koren G., Lishner M., and Santiago S. The Motherisk Guide to Cancer in Pregnancy and Lactation. 2nd ed. (2005), Motherisk program, Toronto
3. Pavlidis N.A. Coexistence of pregnancy and malignancy. Oncologist 7 (2002) 279-287
4. Peleg D., and Ben-Ami M. Lymphoma and leukemia complicating pregnancy. Obstet Gynecol Clin North Am 25 (1998) 365-383
5. Caligiuri M.A., and Mayer R.J. Pregnancy and leukemia. Semin Oncol 16 (1989) 388-396
6. Chrisomalis L., Baxi L.V., and Heller D. Chronic lymphocytic leukemia in pregnancy. Am J Obstet Gynecol 175 (1996) 1381-1382
7. Weisz B., Meirow D., Schiff E., and Lishner M. Impact and treatment of cancer during pregnancy. Exper Rev Anticancer Ther 4 (2004) 889-902
8. Pacifici G.M., and Nottoli R. Placental transfer of drugs administered to the mother. Clin Pharmacokinet 28 (1995) 235-269
9. Cardonick E., and Iacobucci A. Use of chemotherapy during human pregnancy. Lancet Oncol 5 (2004) 283-291
10. Leslie K.K., Koil C., and Rayburn W.F. Chemotherapeutic drugs in pregnancy. Obstet Gynecol Clin North Am 32 (2005) 627-640
11. Zemlickis D., Lishner M., Degendorfer P., Panzarella T., Sutcliffe S.B., and Koren G. Fetal outcome after in utero exposure to cancer chemotherapy. Arch Intern Med 152 (1992) 573-576
12. Doll D.C., Ringenberg Q.S., and Yarbro J.W. Management of cancer during pregnancy. Arch Intern Med 148 (1998) 2058-2064
13. Randall T. National registry seeks scarce data on pregnancy outcomes during chemotherapy. JAMA 269 (1993) 323
14. Asker C., Wikner B., and Kallen B. Use of antiemetic drugs during pregnancy in Sweden. Eur J Clin Pharmacol 61 (2005) 899-906
15. Einarson A., Maltepe C., Navioz Y., Kennedy D., Tan M.P., and Koren G. The safety of ondansetron for nausea and vomiting of pregnancy: a prospective comparative study. BJOG 111 (2004) 940-943
16. Lynch C.M., Sinnott IV J.T., Holt D.A., and Herold A.H. Use of antibiotics during pregnancy. Am Fam Physician 43 (1991) 1365-1368
17. Czeizel A.E., Rockenbauer M., Sorensen H.T., and Olsen J. The teratogenic risk of trimethoprim-sulfonamides: a population based case-control study. Reprod Toxicol 15 (2001) 637-646
18. King C.T., Rogers P.D., Cleary J.D., and Chapman S.W. Antifungal therapy during pregnancy. Clin Infect Dis 27 (1998) 1151-1160
19. Sobel J.D. Use of antifungal drugs in pregnancy: a focus on safety. Drug Saf 23 (2000) 77-85
20. Aviles A., and Neri N. Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero. Clin Lymphoma 2 (2001) 173-177
21. Nulman I., Laslo D., Fried S., Uleryk E., Lishner M., and Koren G. Neurodevelopment of children exposed in utero to treatment of maternal malignancy. Br J Cancer 85 (2001) 1611-1618
22. Kawamura S., Yoshike M., Shimoyama T., et al. Management of acute leukemia during pregnancy: From the results of a nationwide questionnaire survey and literature survey. Tohoku J. Exp. Med 174 (1994) 167-175
23. Greenlund L.I.S., Letendre L., and Tefferi A. Acute leukemia during pregnancy: A single institution experience with 17 cases. Leuk Lymph 41 (2001) 571-577
24. http://www.utdol.com/utd/content/topic.do?topicKey=drug_a_k/69863&drug=true.
25. Hahn K.M., Johnson P.H., Gordon N., et al. Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer 107 (2006) 1219-1226
26. Aviles A., Neri N., and Nambo M.J. Long term evaluation of cardiac function in children who received anthracyclines during pregnancy. Ann Oncol 17 (2006) 286-288
27. Lishner M., Zemlickis D., Degendorfer P., Panzarella T., Sutcliffe S.B., and Koren G. Maternal and fetal outcome following Hodgkin's disease in pregnancy. Br J Cancer 65 (1992) 114-117
28. Pereg D., Koren G., and Lishner M. The treatment of Hodgkin's and non-Hodgkin's lymphoma in pregnancy. Haematologica 92 (2007) 1230-1237
29. Germann N., Goffiner F., and Godwasser F. Anthracyclines during pregnancy: embryo-fetal outcome in 160 patients. Ann Oncol 15 (2004) 146-150
30. Breccia M., Cimino G., Alimena G., De Carolis S., Lo Coco F., and Mandelli F. AIDA treatment for high-risk acute promyelocytic leukemia in a pregnant woman at 21 weeks of gestation. Haematologica 87 (2002) ELT12
31. Siu B.L., Alonzo M.R., Vargo T.A., and Fenrich A.L. Transient dilated cardiomyopathy in a newborn exposed to idarubicin and all-trans-retinoic acid (ATRA) early in the second trimester of pregnancy. Int J Gynecol Cancer 12 (2002) 399-402
32. Celo J.S., Kim H.C., Houlihan C., Canavan B.F., Manzullo G.P., and Saidi P. Acute promyelocytic leukemia in pregnancy: all-trans retinoic acid as a newer therapeutic option. Obstet Gynecol 83 (1994) 808-811
33. Delgado-Lamas J.L., and Garcés-Ruiz O.M. Acute promyelocytic leukemia in late pregnancy. Successful treatment with All-Trans-Retinoic Acid (ATRA) and Chemotherapy. Hematology 4 (2000) 415-418
34. Harrison P., Chipping P., and Fothergill G.A. Successful use of all-trans retinoic acid in acute promyelocytic leukaemia presenting during the second trimester of pregnancy. Br J Haematol 86 (1994) 681-682
35. Incerpi M.H., Miller D.A., Posen R., and Byrne J.D. All-trans retinoic acid for the treatment of acute promyelocytic leukemia in pregnancy. Obstet Gynecol 89 (1997) 826-828
36. Stentoft J., Nielsen J.L., and Hvidman L.E. All-trans retinoic acid in acute promyelocytic leukemia in late pregnancy. Leukemia 8 (1994) 1585-1588
37. Molkenboer J.F., Vos A.H., Schouten H.C., and Vos M.C. Acute lymphoblastic leukaemia in pregnancy. Neth J Med 63 (2005) 361-363
38. Chelghoum Y., Vey N., Raffoux E., et al. Acute leukemia during pregnancy: a report on 37 patients and a review of the literature. Cancer 104 (2005) 110-117
39. Hansen W.F., Fretz P., Hunter S.K., and Yankowitz J. Leukemia in pregnancy and fetal response to multiagent chemotherapy. Obstet Gynecol 97 (2001) 809-812
40. Bergstrom S.K., and Altman A.J. Pregnancy during therapy for childhood acute lymphoblastic leukemia: two case reports and a review of the literature. J Pediatr Hematol Oncol 20 (1998) 154-159
41. Milunsky A., Graef J.W., and Gaynor Jr. M.F. Methotrexate-induced congenital malformations. J Pediatr 72 (1968) 790-795
42. Powell H.R., and Ekert H. Methotrexate-induced congenital malformations. Med J Aust 2 (1971) 1076-1077
43. Diniz E.M., Corradini H.B., Ramos J.L., and Brock R. Effect on the fetus of methotrexate (amethopterin) administered to the mother. Presentation of a case. Rev Hosp Clin Fac Med Sao Paulo 33 (1978) 286-290
44. Dara P., Slater L.M., and Armentrout S.A. Successful pregnancy during chemotherapy for acute leukemia. Cancer 47 (1981) 845-846
45. Feliu J., Juarez S., Ordonez A., Garcia-Paredes M.L., Gonzalez-Baron M., and Montero J.M. Acute leukemia and pregnancy. Cancer 61 (1988) 580-584
46. Kozlowski R.D., Steinbrunner J.V., MacKenzie A.H., Clough J.D., Wilke W.S., and Segal A.M. Outcome of first-trimester exposure to low-dose methotrexate in eight patients with rheumatic disease. Am J Med 88 (1990) 589-592
47. Buckley L.M., Bullaboy C.A., Leichtman L., and Marquez M. Multiple congenital anomalies associated with weekly low-dose methotrexate treatment of the mother. Arthritis Rheum 40 (1997) 971-973
48. Bawle E.V., Conard J.V., and Weiss L. Adult and two children with fetal methotrexate syndrome. Teratology 7 (1998) 51-55
49. Addar M.H. Methotrexate embryopathy in a surviving intrauterine fetus after presumed diagnosis of ectopic pregnancy: case report. J Obstet Gynaecol Can 26 (2004) 1001-1003
50. In: De Vita V.T., Hellman S., and Rosenberg S.A. (Eds). Cancer, principles and practice of oncology. 7th ed. (2001), Lippincot Williams & Wilkins, Philadelphia 2121
51. Mesquita M.M., Pestana A., and Mota A. Succesful pregnancy occurring with interferon-alpha therapy in chronic myelod leukemia. Acta Obste Gynecol Scand 84 (2005) 300-301
52. Goldman J.M. How I treat chronic myeloid leukemia in the imatinib era. Blood 110 (2007) 2828-2837
53. Cohen M.H., Johnson J.R., and Pazdur R. US Food and Drug Administration drug approval summary: Conversion of imatinib mesylate tablets from accelerated approval to full approval. Clin Can Res 11 (2005) 12-19
54. Russell M.A., Carpenter M.W., Akhtar M.S., Lagattuta T.F., and Gorin M.J. Imatinb mesylate and metabolite concentrations in maternal blood, umbilical cord blood, placnta and breast milk. Journal of Perinatol 27 (2007) 241-243
55. Garderet L., Santacruz R., Barbu V., van den Akker J., Carbonne B., and Gorin N.C. Two successful pregnancies in chronic myeloid leukemia patient treated with imatinib. Haematologica 92 (2007) ECR05
56. Choundhary D.R., Mishra P., Kumar R., Mahapatra M., and Choundary V.P. Pregnancy on imatinib: fatal outcome with meningocele. Ann Oncol 17 (2006) 178-179
57. Ault P., Kantarjian H., O'Brien S., et al. Pregnancy among patients with CML treated with Imatinib. JCO 24 (2006) 1204-1208
58. Suppiah R., and Kalaycio M. Successful outcome of pregnancy in a patient with chronic myelogenous leukemia exposed to imatinib during the first trimester. Leuk Lymphoma 47 (2006) 1149-1150
59. Alkindi S., Dennison D., and Pathare A. Imatinib in pregnancy. Eur J haematol 74 (2005) 535-537
60. Prabash K., Sastry P.S.R.K., Biswas G., et al. Pregnancy outcome of two patients treated with imatnib. Ann Oncol 16 (2005) 1983-1984
61. Ali R., Ozkalemkas F., Ozcelik T., et al. Pregnancy under treatment of imatinib and successful labor in patient with chronic myelogenous leukemia. Outcome of discontinuation of imatinib therapy after achieving a molecular remission. Leuk Res 29 (2005) 971-973
62. Heartin E., Walkinshow S., and Clarck R.E. Successful outcome of pregnancy in chronic myeloid leukaemia treated with imatinib. Leuk Lymphoma 45 (2004) 1307-1308
63. Mauro M.J., Druker B.J., and Maziarz R.T. Divergent clinical outcome in two CML patients who discontinued imatinib therapy after achieving a molecular remission. Leuk Res 28S1 (2004) S71-S73
64. Cortes J., O'Brien S., and Kantarjian H. Discontinuation of imatinib therapy after achieving a molecular response. Blood 104 (2004) 2204-2205
65. Roth M.S., and Foon K.A. Alpha interferon in the treatment of hematologic malignancies. Am J Med 81 (1986) 871-882
66. Mubarak A.A.S., Kakil I.R., Awidi A., et al. Normal outcome of pregnancy in chronic myeloid leukemia treated with interferon-α in 1st trimester: report of 3 cases and review of the literature. Am J Hematol 69 (2002) 115-118
67. Hiratsuka M., Minakami H., Koshizuka S., and Sato I. Administration of interferon-α during pregnancy: effect on fetus. J Perinat Med 28 (2000) 372-376
68. Vantroyen B., and Vanstraelen D. Management of essential thrombocythemia during pregnancy with aspirin, interferon alpha 2a and no treatment. A comprehensive analysis of the literature. Acta Hematol 107 (2002) 158-169
69. Regierer A.C., Schulz C.O., Kuehnhardt D., Flath B., and Possinger K. Interferon α - therapy for chronic myeloid leukemia during pregnancy. Am J Hematol 81 (2006) 149-156
70. Al Bahar S., Pandita R., and Nath S.V. Pregnancy in chronic myeloid leukemia patients treated with alpha interferon. Int J Gynecol Obstet 85 (2004) 281-282
71. Kuroiwa M., Gondo H., Ashida K., et al. Interferon alpha therapy for chronic myeloid leukemia during pregnancy. Am J Hematol 59 (1998) 101-102
72. Haggstrom J., Adrinsson M., Hybbinette T., Harnby E., and Thornbert G. Two cases of CML treated with alpha-Interferon during second and third trimester of pregnancy with analysis of the drug in the newborn immediately postpartum. Eur J Haematol 57 (1996) 101-102
73. http://www.utdol.com/utd/content/topic.do?topicKey=leukemia/15171&type=A&selectedTitle=3~33.
74. Fadila S.A.W., Ahmad-Zaliani H., Soon-Keng C., and Norlaila M. Successful treatment of chronic myeloid leukemia during pregnancy with hydroxyurea. Leukemia 16 (2002) 1202-1203
75. Celiloglu M., Altunyurt S., and Undar B. Hydroxyurea treatment for CML during pregnancy. Acta Obstet Gynecol Scand 79 (2000) 803-804
76. Jackson N., Shukri A., and Kamaruzan A. Hydroxyurea treatment for CML during pregnancy. Br J Haematol 85 (1993) 203-204
77. Delmer A., Rio B., Bauduer F., Ajehenbaum F., Marie J.P., and Zittoun R. Pregnancy during myelosuppressive treatment for CML. Br J Haematol 82 (1992) 783-784
78. Tertian G., Tchernia G., Papiernik E., and Elefant E. Hydroxyurea and pregnancy. Am J Obstet Gynecol 18 (1992) 68-74
79. Patel M., Dukes I.A.F., and Hull J.C. Use of hydroxyurea in CML during pregnancy: a case report. Am J Obstet Gynecol 165 (1991) 565-566
80. Thauvin Robinet C., Maingueneau C., Robert E., et al. Exposure to hydroxyurea during pregnancy: a case series. Leukemia 15 (2001) 1309-1311
81. Ali R., Ozkalemkaş F., Ozkocaman V., et al. Successful pregnancy and delivery in patient with CML and management of CML with leukapheresis during pregnancy. Jpn J Clin Oncol 34 (2004) 215-217
82. Klaasen R., de-Jong P., and Wijermans P.W. Successful management of chronic myeloid leukemia with leucapheresis during a twin pregnancy. Neth J Med 65 (2007) 147-149
83. Robak T. Current treatment options in hairy cell leukemia and hairy cell leukemia variant. Cancer Treat Rev 32 (2006) 365-376
84. Stiles G.M., Stanco L.M., Saven A., and Hoffmann K.D. Splenecomy for hairy cell leukemia during pregnancy. J Perinatol 18 (1998) 200-201
85. Alothman A., and Sparling T.G. Managing hairy cell leukemia in pregnancy. Ann Intern Med 120 (1994) 1048-1049
86. Baer M.R., Ozer H., and Foon K.A. Interferon alpha therapy during pregnancy in chronic myelogenous leukemia and hairy cell leukemia. Br J Hematol 81 (1992) 167-169
87. Williams J.K. Hairy cell leukemia in pregnancy: a case report. Am J Obstet Gynecol 156 (1987) 210-211
88. Patsner B., Penney R.W., and Walsh C.M. Recurrent hairy cell leukemia during pregnancy: a case report. Am J Obstet Gynecol 170 (1994) 1380-1381
89. http://www.cancer.gov/cancertopics/pdq/treatment/CLL/healthprofessional/.
90. Gurman G. Pregnancy and successful labor in the course of chronic lymphocytic leukemia. Am J Hematol 71 (2002) 208-210
91. Welsh T.M., Thompson J., and Lim S. Chronic lymphocytic leukemia in pregnancy. Leukemia 14 (2000) 1155
92. Chrisomalis L., Baxi L.V., and Heller D. Chronic lymphocytic leukemia in pregnancy. Am J Obstet Gynecol 175 (1996) 1381-1382
93. Padmanabhan R., and Samad P.A. Chlorambucil-induced postclosure exencephaly and axial skeletal abnormalities in rat fetuses. Reprod Toxicol 13 (1999) 189-201
94. Salder T.W., and Kochhar D.M. Teratogenic effects of chlorambucil on in vivo and in vitro organogenesis in mice. Teratology 12 (1975) 71-78
95. Kavlock R.J., Rhenberg B.F., and Rogerts E.H. Chlorambucil induced congenital renal hypoplasia: effects on basal renal function in developing rat. Toxicology 40 (1986) 247-258
96. Nicholson H.O. Cytotoxic drugs in pregnancy. Review of reported cases. J Obstet Gynaecol Br Commonw 75 (1968) 307-312
97. Jacobs C., Donaldson S.S., Rosenberg S.A., and Kaplan H.S. Management of the pregnant patient with Hodgkin's disease. Ann Intern Med 95 (1981) 669-675
98. Ba-Thike K., and Oo N. Non-Hodgkin's lymphoma in pregnancy. Asia Oceania J Obstet Gynaecol 16 (1990) 229-232
99. Shoton D., and Monie I.W. Possible teratogenic effect of chlorambucil on a human fetus. JAMA 186 (1963) 180-181
100. Steege J.F., and Caldwell D.S. Renal agenesis after first trimester exposure to chlorambucil. South Med J 73 (1980) 1414-1415
101. Blanford A., and Murphy B.P. In vitro metabolism of prednisolone, dexamethsone, betamethasone and cortisol by the human placenta. Am J Obstet Gynecol 27 (1977) 264-267
102. In: Hardman J.G., and Limbird L.E. (Eds). Goodman and Gilman's the pharmacological basis of therapeutics. 10th ed. (2001), McGrow-Hill, New York 1668
103. van Runnard Heimel P.J., Franx A., Schobben A.F.A.M., Huisjes A.J.M., Derks J.B., and Bruinse H.W. Corticosteroids, pregnancy, and HELLP syndrome: A review. Obstet gynecol surv 60 (2005) 57-70
104. American College of Rheumatology Ad Hoc committee on clinical guidelines. Guidelines for monitoring drug therapy in rheumatoid arthritis. Arthritis Rheum 1996;39:723-31.
105. Janssen N.M., and Genta M.S. The effect of immunosuppressive and anti-inflammatory medications on fertility, pregnancy and lactation. Arch Int Med 160 (2000) 610-619
106. Matalon S.T., Ornoy A., and Lishner M. The effect of 6-mercaptopurine on early human placental explants. Hum Reprod 20 (2005) 1390-1397
107. DeLoia J.A., Stewart-Akers A.M., and Creinin M.D. Effects of methotrexate on trophoblast proliferation and local immune responses. Hum Reprod 13 (1998) 1063-1069
108. Matalon S.T., Ornoy A., and Lishner M. Review of the potential effects of three commonly used antineoplastic and immunosuppressive drugs (cyclophosphamide, azathioprine, doxorubicin) on the embryo and placenta. Reprod Toxicol 18 (2004) 219-230
109. Kraemer J., Klein J., Lubetsky A., and Koren G. Perfusion studies of glyburide transfer across the human placenta: implications for fetal safety. Am J Obstet Gynecol 195 (2006) 270-274
110. Hnat M., and Bawdon R.E. Transfer of meropenem in the ex vivo human placenta perfusion model. Infect Dis Obstet Gynecol 13 (2005) 223-227
111. Polachek H., Holcberg G., Sapir G., et al. Transfer of ciprofloxacin, ofloxacin and levofloxacin across the perfused human placenta in vitro. Eur J Obstet Gynecol Reprod Biol 122 (2005) 61-65